Skip to main navigation Skip to search Skip to main content

Enterococcus faecalis infective endocarditis: focus on clinical aspects

Anders Dahl, Niels Eske Bruun

58 Citations (Scopus)

Abstract

Enterococcus faecalis infective endocarditis (IE) is a disease of increasing importance, with more patients infected, increasing frequency of health-care associated infections and increasing incidence of antimicrobial resistances. The typical clinical presentation is a subacute course with fever, malaise and generalized aches, difficult to distinguish from other more common diseases. Of paramount importance is transthoracic- and transesophageal-echocardiography to establish the diagnosis. At the moment, the predominant strategies recommend ampicillin in combination with either gentamicin or ceftriaxone. E. faecalis infective endocarditis continues to be a very serious disease with considerable percentages of high-level gentamicin resistant strains and in-hospital mortality around 20%. Strategies to prevent E. faecalis IE, improve diagnostics, optimize treatment and reduce morbidity will be necessary to improve the overall prognosis.

Original languageEnglish
JournalExpert Review of Cardiovascular Therapy
Volume11
Issue number9
Pages (from-to)1247-57
Number of pages11
ISSN1477-9072
DOIs
Publication statusPublished - Sept 2013

Keywords

  • Ampicillin
  • Anti-Bacterial Agents
  • Ceftriaxone
  • Drug Therapy, Combination
  • Endocarditis, Bacterial
  • Enterococcus faecalis
  • Humans

Fingerprint

Dive into the research topics of 'Enterococcus faecalis infective endocarditis: focus on clinical aspects'. Together they form a unique fingerprint.

Cite this